185 related articles for article (PubMed ID: 26998059)
1. Initial evidence for Sec62 as a prognostic marker in advanced head and neck squamous cell carcinoma.
Wemmert S; Lindner Y; Linxweiler J; Wagenpfeil S; Bohle R; Niewald M; Schick B
Oncol Lett; 2016 Mar; 11(3):1661-1670. PubMed ID: 26998059
[TBL] [Abstract][Full Text] [Related]
2. Expression of 3q Oncogene SEC62 Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients Treated with Primary Chemoradiation.
Linxweiler M; Schneider M; Körner S; Knebel M; Brust LA; Braun FL; Wemmert S; Wagner M; Hecht M; Schick B; Kühn JP
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201525
[TBL] [Abstract][Full Text] [Related]
3. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
[TBL] [Abstract][Full Text] [Related]
4. Dual Sec62/Ki67 immunocytochemistry of liquid-based cytological preparations represents a highly valid biomarker for non-invasive detection of head and neck squamous cell carcinomas.
Kühn JP; Speicher S; Linxweiler B; Körner S; Rimbach H; Wagner M; Solomayer EF; Schick B; Linxweiler M
Cytopathology; 2024 Jan; 35(1):113-121. PubMed ID: 37787092
[TBL] [Abstract][Full Text] [Related]
5. Expression of 3q oncogene
Müller CSL; Kreie L; Bochen F; Pfuhl T; Smola S; Gräber S; Vogt T; Schick B; Linxweiler M
Oncol Lett; 2019 Feb; 17(2):1768-1776. PubMed ID: 30675236
[TBL] [Abstract][Full Text] [Related]
6. Identification of 3q oncogene SEC62 as a marker for distant metastasis and poor clinical outcome in invasive ductal breast cancer.
Takacs FZ; Radosa JC; Linxweiler M; Kasoha M; Bohle RM; Bochen F; Unger C; Solomayer EF; Schick B; Juhasz-Böss I
Arch Gynecol Obstet; 2019 May; 299(5):1405-1413. PubMed ID: 30747329
[TBL] [Abstract][Full Text] [Related]
7. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.
Young RJ; Rischin D; Fisher R; McArthur GA; Fox SB; Peters LJ; Corry J; Lim A; Waldeck K; Solomon B
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1230-7. PubMed ID: 21467228
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
9. [Association of the expression of p53 and p16INK4A with the clinical and morphological characteristicsof patients with head and neck squamous cell cancer].
Stukan AI; Chukhray OY; Porkhanov VA; Bodnya VN
Arkh Patol; 2019; 81(3):12-18. PubMed ID: 31317926
[TBL] [Abstract][Full Text] [Related]
10. The association of (18)F-FDG PET and glucose metabolism biomarkers GLUT1 and HK2 in p16 positive and negative head and neck squamous cell carcinomas.
Baschnagel AM; Wobb JL; Dilworth JT; Williams L; Eskandari M; Wu D; Pruetz BL; Wilson GD
Radiother Oncol; 2015 Oct; 117(1):118-24. PubMed ID: 26328941
[TBL] [Abstract][Full Text] [Related]
11. p16(INK4a) status and survival benefit of EGFR inhibitors in head and neck squamous cell cancer: A systematic review and meta-analysis.
Su Y; Cui J; Xu D; Wang M; Xu T; Tian H; Han F
Crit Rev Oncol Hematol; 2018 Apr; 124():11-20. PubMed ID: 29548481
[TBL] [Abstract][Full Text] [Related]
12. Antagonizing Sec62 function in intracellular Ca
Körner S; Pick T; Bochen F; Wemmert S; Körbel C; Menger MD; Cavalié A; Kühn JP; Schick B; Linxweiler M
Front Physiol; 2022; 13():880004. PubMed ID: 36045752
[TBL] [Abstract][Full Text] [Related]
13. [Cetuximab in head and neck squamous cell carcinoma: a systematic review and Meta-analysis].
Song Q; Li X; Li B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(1):67-75. PubMed ID: 25966559
[TBL] [Abstract][Full Text] [Related]
14. Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.
Alterio D; Marvaso G; Maffini F; Gandini S; Chiocca S; Ferrari A; Preda L; Rocca MC; Lepanto D; Fodor C; Volpe S; Dicuonzo S; Laudati A; Giugliano G; Ansarin M; Jereczek-Fossa BA
Med Oncol; 2017 Jun; 34(6):107. PubMed ID: 28452036
[TBL] [Abstract][Full Text] [Related]
15. Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma.
Koh Y; Kim TM; Jeon YK; Kwon TK; Hah JH; Lee SH; Kim DW; Wu HG; Rhee CS; Sung MW; Kim CW; Kim KH; Heo DS
Ann Oncol; 2009 Aug; 20(8):1414-9. PubMed ID: 19468031
[TBL] [Abstract][Full Text] [Related]
16. Expression of
Müller CSL; Pföhler C; Wahl M; Bochen F; Körner S; Kühn JP; Bozzato A; Schick B; Linxweiler M
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915997
[No Abstract] [Full Text] [Related]
17. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
18. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.
Chandrasekara S; Davis S; Thomson P; Haydon A
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e442-e447. PubMed ID: 29345108
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H
Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646
[TBL] [Abstract][Full Text] [Related]
20. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
